Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending December 11, 2013. The report details a specific share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on capital structure and share buyback activity.
- Shares Purchased: 317,000 Ordinary Shares of 25 pence each.
- Purchase Date: December 11, 2013.
- Price Range: Highest price paid was 1,582.00 pence per share; lowest price paid was 1,577.00 pence per share.
- Treasury Holdings (Settled): 515,018,909 shares (9.59% of total issued share capital).
- Treasury Holdings (Including Unsettled): 516,339,909 shares (10.63% of total voting rights).
- Shares in Issue (Excluding Treasury): 4,856,845,827 shares.
Material Changes
The filing reports a reduction in outstanding shares due to the purchase of 317,000 shares for treasury. Consequently, the percentage of total voting rights held in treasury increased to 10.63% when including unsettled purchases. No other material changes to operations or financial position are disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total number of shares held in treasury (515,018,909 settled) against the company's latest annual report.
- Confirm the total issued share capital to validate the 9.59% treasury ownership calculation.
- Check the settlement status of the 1,321,000 shares (difference between settled and total treasury holdings) to confirm the 10.63% voting rights figure.
- Review the Financial Conduct Authority's Disclosure and Transparency Rules to understand notification thresholds for shareholders based on the 4,856,845,827 shares in issue.